SEE FULL COMPANY PROFILES WITH A FREE TRIAL
EMIS is the definitive emerging markets news, research, company, and financial data resource. EMIS - ISI Emerging MarketsLEARN MORE
Search for another company:
ALL
Romania
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).

Pasteur - Filiala Filipesti

Main Activities: Pharmaceutical and Medicine Manufacturing

facebook Please check the full coverage of information what EMIS can offer you. SEE SAMPLE

Company Information

Full name
Pasteur - Filiala Filipesti SRL

Headquarters
944, Principala St.; FILIPESTII DE PADURE; Prahova
Status: Non-Listed
Legal Form: Limited Liability Company
Operational Status: Operational
CUI: 11928947
Incorporation Date: January 1, 1999
Total Employees: 320

Tel: 00 40-244-386.888; 0244-386699

Company Description

Established in 1999, S.C. PASTEUR - FILIALA FILIPEŞTI S.R.L. observes the tradition of the National Pasteur Institute, representing today a reference unit of the Romanian veterinary, with a portfolio over 500 products.
The company is build up of 7 production sections modernly fitted: comprimation section, powder section, raticide and insecticide section, pet accessories section, detergents and disinfectants section, liquids section, injectables section.

Company Analysis

According to the Individual - Non-Audited financial statement for the Year of 2011, total net operating revenues increased with 17.13%, from RON 44,549,826 to RON 52,182,765 . Operating result decreased from RON 13,854,492 to RON 7,610,463 which means -45.07% change. The results of the period decreased -44.96% reaching RON 6,007,874 at the end of the period against RON 10,915,027 last year. Return on equity (Net income/Total equity) went from 19.58% to 11.56%, the Return On Asset (Net income / Total Asset) went from 15.53% to 8.71% and the Net Profit Margin (Net Income/Net Sales) went from 24.50% to 11.51% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 32.77% compared to 26.09% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 2.25 to 1.70 when compared to the previous year.

Key Executives

Sorin Paul Stanescu General Manager
More

Companies with Similar Main Activities

ISI Emerging Markets

FULL COMPANY PROFILE

Please check the full coverage of information what EMIS can offer you.
SEE SAMPLE
SELECT CURRENCY
Balance Sheet

Total Assets

69,006,801

76,802,746

Current Assets

XX,XXX,XXX

XX,XXX,XXX

Total Liabilities

XX,XXX,XXX

XX,XXX,XXX

Shareholders Equity

XX,XXX,XXX

XX,XXX,XXX

Current Liabilities

XX,XXX,XXX

XX,XXX,XXX

* All the accounts are in RON.
Income Statement

Total Operating Revenue

XX,XXX,XXX

XX,XXX,XXX

Operational Profit (Loss)

X,XXX,XXX

X,XXX,XXX

Net Profit (Loss)

X,XXX,XXX

X,XXX,XXX

* All the accounts are in RON.
Ratios
Profitability Ratios

Return on Assets (ROA)

X.XX%

X.XX%

Annualised Return on Assets (ROA)

X.XX%

XX.XX%

Return on Equity (ROE)

XX.XX%

XX.XX%

Annualised Return on Equity (ROE)

XX.XX%

XX.XX%

Return on Sales (ROS)

XX.XX%

XX.XX%

Return on Capital

XX.XX%

XX.XX%

Gross Profit Margin

XX.XX%

XX.XX%

Operating Profit Margin

XX.XX%

XX.XX%

Efficiency Ratios

Accounts Receivable Turnover

X.XXx

X.XXx

Inventory Turnover

X.XXx

X.XXx

Current asset turnover

X.XXx

X.XXx

Fixed-asset turnover

X.XXx

X.XXx

Asset Turnover

X.XXx

X.XXx

Valuation figures and ratios

Earning Before Interests and Taxes (EBIT)

X,XXX,XXX

X,XXX,XXX

EBITDA

X,XXX,XXX

X,XXX,XXX

Bookvalue (BV)

XX,XXX,XXX

XX,XXX,XXX

Net Cash

-XX,XXX,XXX

-XX,XXX,XXX

Liquidity Ratios

Current Ratio

XXX.XX%

XXX.XX%

Quick ratio

XXX.XX%

XXX.XX%

Doom's day ratio

X.XX%

X.XX%

Leverage Ratios

Leverage ratio

XXX.XX%

XXX.XX%

Interest Coverage Ratio

XXX.XX%

Debt to equity

XX.XX%

XX.XX%

Debt to total assets

XX.XX%

XX.XX%

Long Term Debt to Capital

XX.XX%

X%